- Lobbying
- lilly AND usa
Lobbying Arrangements Results for 'Lilly Usa'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details matters pertaining to pharmacy matters |
Lilly USA
|
Roetzel & Andress, LPA | |||
Details Healthcare Reform Bill - 340B Drug Program Extension |
Lilly USA, LLC
|
Bose Public Affairs Group | |||
Details Lilly Ledbetter Fair Pay Act; Paycheck Fairness Act FMLA, paid parental leave, paid sick days, workplace flexibility, child care HEART for Women Act |
BUSINESS AND PROFESSIONAL WOMEN/USA
|
in-house lobbying | |||
Details Opposition to prescription drug importation and cuts to Medicare Part D funding. Support for funding of Department of Homeland Security drug interdiction efforts. Issues related to pricing of presc... |
Lilly USA LLC
|
FORGE Federal Affairs LLC | |||
Details Issues related to prescription drugs, including reimbursement for prescription drugs. Issues related to prescription drugs, including reimbursement for prescription drugs under these programs. |
Lilly USA, LLC
|
FrogueClark, LLC | |||
Details Federal policy involving energy. Federal policy involving government issues. |
Evergreen Community Power, LLC
|
Abraham & Roetzel, LLC | |||
Details Monitor legislative discussions on 21st Century Cures (H.R. 6) and Senate biomedical innovation bills; Support Medicare reimbursment for diagnostic testing of Alzheimer's disease; Oppose CMMI propo... |
Lilly USA, LLC
Pharmaceutical development and manufacturing |
Republic Consulting, LLC | |||
Details Issues related to Insulin pricing, Issues regarding the 340B Drug Pricing Program. Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Ant... |
Lilly USA, LLC
|
Forbes-Tate | |||
Details FDA's accelerated approval pathway; insulin price cap; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; Pandemic and All-Hazards Preparedness Reauthorization Act ... |
Lilly USA, LLC
|
Crossroads Strategies, LLC | |||
Details Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act |
Lilly USA, LLC
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP |